Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-24-009362
Filing Date
2024-08-15
Accepted
2024-08-15 12:36:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27689
2 filename2.txt TEXT-EXTRACT 1183
  Complete submission text file 0000000000-24-009362.txt   40085
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filed for) CIK: 0001501989 (see all company filings)

EIN.: 273521219 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-281433
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)